breakingview  bristol myer deal gambl pai  twice 
new york reuter breakingview  bristol myer squibb  land two bird   bush   134 billion u drug firm agre  bui rival oncolog specialist celgen  74 billion  2019    divest  autoimmun drug  satisfi regul instead  keep celgenâ€™ proven blockbust otezla  sold  drug  amgen  134 billion keep  unproven candid instead   rare headhead trial compar  two drug suggest boss giovanni caforio got  better end    possibl two big deal
